- ‘Unsafe Abortions Driving Preventable Maternal Deaths’
- Born With It or Brought On by the Air? The Many Faces of Chronic Lung Disease in Children
- Government Targets Neonatal Mortality Below 12 per 1,000 by 2030
- Medical Aid Clinics at Risk as Government Moves to Tighten Regulations
- Africa CDC, UZ Train New Cohort to Tackle Mental Health Burden
In Search For An Elusive HIV Vaccine: Zimbabwean Scientists Dig Deeper For Answers after Imbokodo Trials
By Michael Gwarisa Over the past few years, several interventions have been developed as the world intensifies the fight against HIV and AIDS. These include combined strategies such as behavioral, biomedical, and surgical methods to prevent HIV like Voluntary Medical Male Circumcision (VMMC). For other epidemics such as smallpox, polio, measles and COVID-19, vaccines saved the
Read More
Mutating HIV Virus Making It Difficult To Develop Vaccine
THE ever-changing genetic makeup and rapid mutation of the HIV virus has to a larger extent slowed down progress towards successfully developing an effective HIV vaccine, a top Zimbabwean expert has said. By Michael Gwarisa The revelations also follow the recent abandonment of the Imbokodo HIV vaccine or HVTN 705/HPX2008 efficacy studies after revelations that
Read MoreImbokodo HIV Vaccine Study Was A Learning Phase
Dr Portia Hunidzarira, the Imbokodo Principal Researcher said the discontinuation of the HVTN 705/HPX2008 or Imbokodo study gave researchers and scientist a new platform to learn and develop evidence for future studies that might lead to an HIV vaccine breakthrough. By Patricia Mashiri She said the vaccine proved to be safe and caused no harm
Read MoreHIV Vaccine Trials Discontinued After It Fails To Prevent HIV Infection
THE HVTN 705/HPX2008 or Imbokodo study, which began in 2017 to test whether the Imbokodo vaccine regimen could prevent women in Sub-Saharfan Africa from getting HIV has been discontinued following indications that the vaccine did not provide sufficient protection against infection. By Michael Gwarisa In a statement, Johnson & Johnson said data showed the investigational
Read More
Researchers Not Giving Up On Imbokodo HIV Vaccine Study
PERSISTENT researchers feel the halted HTVN 702 study on the efficacy of an HIV vaccine will not affect the Imbokodo Vaccine Trial study launched in 2017. By Kudakwashe Pembere HVTN 702 study was stopped following an interim analysis conducted on 23 January 2020 by an independent Data and Safety Monitoring Board (DSMB) that reviews all
Read More